During the last session, Nuvation Bio Inc (NYSE:NUVB)’s traded shares were 3.94 million, with the beta value of the company hitting 1.42. At the end of the trading day, the stock’s price was $2.10, reflecting an intraday gain of 2.94% or $0.06. The 52-week high for the NUVB share is $3.97, that puts it down -89.05 from that peak though still a striking 26.67% gain since the share price plummeted to a 52-week low of $1.54. The company’s market capitalization is $713.30M, and the average trade volume was 2.89 million shares over the past three months.
Nuvation Bio Inc (NUVB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. NUVB has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it.
Nuvation Bio Inc (NYSE:NUVB) trade information
Nuvation Bio Inc (NUVB) registered a 2.94% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.94% in intraday trading to $2.10, hitting a weekly high. The stock’s 5-day price performance is -7.49%, and it has moved by 26.51% in 30 days. Based on these gigs, the overall price performance for the year is -33.96%.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 65.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, NUVB is trading at a discount of -185.71% off the target high and -185.71% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -49.14%. While earnings are projected to return 69.61% in 2025, the next five years will return 37.79% per annum.
NUVB Dividends
Nuvation Bio Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 19.21 million shares, is of ECOR1 CAPITAL, LLC’s that is approximately 7.8491% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $56.09 million.
Also, the Mutual Funds coming in first place with the largest holdings of Nuvation Bio Inc (NUVB) shares are Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Mar 31, 2025 indicates that Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund owns about 15.47 shares. This amounts to just over 4.57 percent of the company’s overall shares, with a $32.48 million market value. The same data shows that the other fund manager holds slightly less at 8.96, or about 2.65% of the stock, which is worth about $18.81 million.
